Formulation Overage: Why a Supplement Contains More Than the Label Says

Assay a fresh bottle of a well-made supplement and it will usually read above its label. A product that says 500 mg might test at 560. That looks like a mistake, or a generous bonus. It’s neither. It’s an engineered buffer called an overage, and getting it right is one of the quieter tests of whether a formula was built by people who understand what a label claim actually promises.

The label isn’t a snapshot of filling day. It’s a promise the product keeps for its whole shelf life, down to the last unit sold on the last day of the expiration date. Actives fade between the blender and that day. So the formula has to start above claim and drift down toward it, landing at or above the number on the label when the date arrives. That’s the whole idea. The interesting part is how far above to start, and what happens when a manufacturer gets it wrong in either direction.

Educational overview: not legal, regulatory, or medical advice. Requirements change and vary by jurisdiction and sales channel. Last reviewed July 2026.

Short answer. A supplement is formulated with more active than the label states because the claim has to hold through the expiration date, not just on filling day. Ingredients degrade, so the formula starts above claim and lands at or above it on the last day. How far above is not a guess or a house default; it’s read from stability data for that exact formula, format, and packaging. Add too little and the product drops below its compliance floor before it expires. Add too much and you pay for active you give away, risk upper-intake ceilings on nutrients like vitamins A and D, and carry a matching load of degradation products.

Best for: Brand owners and formulators protecting label-claim compliance across a product’s shelf life.

Key decision: Whether your overage is set from stability data and kept clear of safety and cost ceilings, or applied as a blanket percentage across products.

Apollo path: Apollo sets overage from how each active behaves at the bench and through vetted third-party stability testing, formula by formula; a manufacturing quote scopes the formulation and the testing together.

What an overage actually is, and the one thing it protects

An overage is the amount by which a formula is built above its label claim. Declare 1,000 mg of vitamin C, blend to 1,150 mg, and you’ve added a 15% overage. The extra 150 mg isn’t a stronger dose you’re quietly handing out. It’s headroom: a reserve that degradation is expected to consume over the months the product sits in a warehouse, on a shelf, and in a cabinet before someone takes the last serving.

It helps to separate overage from two things it’s often confused with. It isn’t manufacturing slop: a well-run blend hits its target tightly, and the overage is a deliberate target set above the label, not the scatter around it (batch-to-batch variation is a separate, smaller input to how much overage you need). And it isn’t the analytical method’s wiggle room: every assay carries measurement uncertainty, and the compliance rules make a small allowance for that. Overage sits on top of the real, physical loss of active over time: the part the chemistry takes, not the part the instrument can’t resolve.

Strip those away and overage protects exactly one thing: your ability to still meet the label claim on the last day the product is legally yours to sell. That is a compliance obligation before it is a quality nicety, which is why the number belongs to the formulation team and the stability program together (see how custom formulation works), not to a spreadsheet default.

The rule that makes overage necessary: 100% of claim, through shelf life

Overage exists because of how the FDA judges whether a supplement matches its label. This is the part most explainer pages wave at without citing, so here it is against the primary source, current as of mid-2026.

Dietary-supplement label compliance is determined under the food-labeling regulation at 21 CFR 101.36(f)(1), which routes to the nutrition-labeling rules of 21 CFR 101.9(g). Two things in that text govern overage directly.

First, 101.9(g) sorts nutrients into two classes for compliance (101.9(g)(3)): Class I: added nutrients in fortified or fabricated foods, and Class II: naturally occurring (indigenous) nutrients. The compliance floors differ by class (101.9(g)(4)): a Class I vitamin, mineral, protein, dietary fiber, or potassium must be present at a level at least equal to the value declared on the label (in plain terms, 100% or more), while a Class II nutrient must be present at at least 80% of the declared value. And 101.36(f)(1) extends those same class I and class II criteria to other dietary ingredients, so the 100%-if-added logic reaches botanicals, amino acids, and the rest of a supplement’s actives, not just the classic vitamins and minerals.

Second (and this is the sentence to keep), 101.36(f)(1) says plainly: “Reasonable excesses over labeled amounts are acceptable within current good manufacturing practice.” That is the regulation blessing overage. It does not require you to add one; it permits a reasonable one. The judgment sits in that word reasonable.

There’s an asymmetry worth seeing, because it explains why overage is a one-way street for most actives. For the ingredients a buyer wants (vitamins, minerals, botanicals, aminos), the rule sets a floor and no ceiling. For a different set of “restrictive” nutrients (calories, total and added sugars, total and saturated fat, cholesterol, and sodium), 101.9(g)(5) sets a ceiling instead: their measured content may not be more than 20% in excess of the declared value. Most of a supplement’s story lives on the floor side. But a functional beverage or a gummy with meaningful sugar or sodium has a real ceiling to respect, and there overage in the wrong direction is a straight violation.

Regulatory citations are provided for orientation and were checked against the Code of Federal Regulations as of mid-2026; they are not legal advice. Which class an ingredient falls in, and how a rule applies to your product and sales channel, is a determination for your regulatory counsel.

Put the floor and the fade together and overage stops being optional in practice. If an added active has to read at least 100% of claim on the expiration date, and it loses potency every month until then, the only way to land at 100% on the last day is to start above it on the first. Overage is what “above it” costs.

Where the active goes: the fade between the blender and the last day

Nothing about a finished supplement is frozen. From the moment a batch is blended, its actives react with heat, moisture, oxygen, light, the pH around them, and sometimes each other, and the rate varies enormously by ingredient. A well-chosen calcium or magnesium form is close to inert and barely moves over two years. Ascorbic acid, many B-vitamins, some botanical markers, omega oils, and live probiotics are the opposite: they fade, and some fade fast.

Three levers set how steep the fade is. The ingredient’s chemistry: how reactive the molecule is, and what form it was sourced in (a coated or protected form, a salt versus a free acid, a stabilized beadlet). The matrix and process: pH, water activity, antioxidants, incompatible ingredients blended in proximity, and the heat and shear of production. The package and shelf: the container, closure, and liner decide how much oxygen and light reach the product, and warehouse and transit decide how hard the clock runs.

Because the fade is measurable, the formulator’s job isn’t to guess a margin. It’s to formulate to the value at expiration: a starting amount that lets the measured decay curve land where the label needs it on the last day. That amount is the overage, and it comes from data, not instinct.

How stability data sets the number: not a guess, not a house default

The overage is an output of the stability program. In a stability study, finished product in its final container is stored under defined conditions and pulled at intervals to measure potency (and microbial and sensory results) as it ages. Real-time storage runs the length of the claim; accelerated storage ages the product faster, using reaction-rate models (the Arrhenius or Q10 approach) to project the real-time slope so a provisional date and overage can be set while real-time confirms them. The mechanics of that study, and how the expiration date is read off it, live in the companion piece on how a supplement’s expiration date is set from stability data; overage and shelf life are two answers read from the same curve.

Here’s the move that turns a decay curve into an overage: read the slope, then back-calculate the start. If a study shows an active losing a tenth of its potency over the shelf life you want, you start high enough that a tenth of the way down still clears 100% of claim, per ingredient, because every active has its own slope. Two actives in the same bottle, on the same shelf life, routinely need different overages. An illustrative example makes the logic concrete: one product, two actives (a fragile one and a stable one), each shown as a percentage of its own label claim across a 24-month shelf life.

Illustrative only: not a prediction for any product or ingredient, and not an Apollo commitment. Real curves are measured for the specific formula, format, and packaging, not assumed.

Read it the way a quality team does. Both actives are formulated to land just above 100% at month 24; that’s the design target. But they start in very different places: the fragile active carries an 18% overage because it sheds potency quickly, while the stable mineral needs only about 4% because it barely moves. Same product, same date, two overages, because the number is set by each ingredient’s behavior, not by a percentage the shop applies to everything. A manufacturer who quotes you “we add 10% overage” as a flat policy is telling you the number wasn’t read from your data. Testing and stability are quoted and run as their own line for exactly this reason; see what testing you actually need.

Why liquids usually need more overage than dry formats

If your product is a liquid (a shot, a tincture, a syrup, a ready-to-drink), expect the overages to run higher than the same actives would need in a capsule, and expect the fragile ingredients to drive the whole conversation. The reason is chemical, and it’s where a liquid-first floor earns its keep.

Water is a reaction medium. In a dry capsule or powder, water activity is low and most actives sit still. Dissolve them in a liquid and you’ve put them where reactions happen: hydrolysis cleaves susceptible molecules, oxidation runs on dissolved oxygen, and pH drifts as the matrix ages and can drag sensitive actives down with it. A liquid also spends its whole life in contact with its packaging, so oxygen through the closure and light through a clear bottle become first-order variables rather than footnotes. Vitamin C is the textbook case: relatively robust as a dry tablet, it can fade quickly in solution, which is why a liquid version of the same claim often needs a substantially larger overage.

How much larger is a formula-by-formula answer. Industry discussion puts a sensitive active like ascorbic acid far higher in a liquid than in a dry format (figures in the low-to-mid twenties of percent get cited for liquid vitamin C against mid-single digits for a stable mineral), but read those as illustrations of the gap, not targets. The only number that governs your product is the one your own stability data returns. What’s reliable is the direction: liquids fade faster, so they carry more overage, so the tension between “enough to meet claim” and “not so much you hit a ceiling” is sharpest exactly where Apollo works. The deeper fix is to cut the fade itself (preservation, pH, antioxidants, protected ingredient forms, packaging), so the formula leans on stabilization first and overage second. Why liquids fade faster covers where that shows up in a quote.

Overage in both directions: the two ways to get it wrong

Most pages frame overage as a one-sided safety margin: more is safer. It isn’t. The number is wrong if it’s too low or too high, and the failure modes are different.

Too little, and the product falls through its floor. If an added active dips below 100% of claim (or a naturally occurring one below 80%) before the expiration date, the regulation deems the product misbranded under the labeling provisions it points to. In practice that surfaces as a failed finished-lot assay, a Certificate of Analysis that won’t support the label, and (if it’s already in the market) recall and marketplace-delisting exposure. Under-dosing the overage doesn’t save money; it defers a much larger bill.

Too much, and a different set of problems opens up. This is the half the benchmark pages skip, and it’s where USP has been sharpest. In a 2019 presentation to its Dietary Supplements Stakeholder Forum, USP’s lead for dietary supplements made the point that the 100%-of-claim rule sets a floor with no upper limit for beneficial nutrients, which “invites” ever-larger overages to chase a long shelf life, an “expensive proposition, not free of risks.” Three risks stand out:

• Safety ceilings. Several nutrients carry a Tolerable Upper Intake Level. Stack a large overage on an already-high label dose and a single serving can drift toward or past that ceiling. USP’s stated position is blunt: overage to compensate for losses “should be used as the last resort and limited to products where toxicity due to vitamin overdose is not a safety concern (not at high doses of vitamin A and D).”
• A matching load of degradation products. Overage doesn’t vanish; it’s active waiting to degrade. As USP put it, an unstable formula “will contain at expiration date an amount of degradation products equal to the overage added to the formulation” (and the toxicity of those breakdown products is not well characterized). A big overage on an unstable active is a big pile of something else by the end of shelf life.
• Label-accuracy and cost. You pay for every milligram of overage and charge for none of it. And gross over-delivery is a consumer-protection target: brands have faced class-action claims alleging that products delivering well above label mislead buyers. Independent analyses back that up: reporting in National Geographic on a Journal of Nutrition review found adult multivitamins averaging roughly 40% more vitamin D than labeled and prenatal products about 26% more iodine, with iodine, vitamin D, and selenium most often exceeding claim by 20% or more. Some of that is prudent headroom; some is overage set by habit rather than data.

The disciplined position, and USP’s, is that overage is a last resort after you’ve stabilized the formula (pH control, antioxidants, protected ingredient forms, the right package), and that the expiration date should follow what the stability data supports, not get fixed first with the overage back-fit to reach it. Setting a long date and then piling on overage to hit it is the exact move that produces the degradation-product and safety problems above.

How overage shows up on your CoA, and why it should

Overage isn’t hidden; it’s visible on your own paperwork if you know where to look. A finished-lot Certificate of Analysis reports the assayed amount of each active (what the batch actually contained when it was tested) against your label claim. For a fresh lot, that assay should read above 100% of claim, because the overage is still mostly intact. That’s expected. A release value sitting exactly at 100.0% on a fragile active is arguably the worrying one: it suggests little headroom for the fade to come.

This is why reading a CoA and understanding overage go together. When you see a release assay of, say, 115% on a sensitive active, that’s the overage (not a bonus dose, and not an error), and the question to ask is whether the stability data shows that 115% landing at or above 100% on the last day of the claimed shelf life. The CoA tells you where the batch starts; the stability study tells you where it ends. Neither alone answers “will this meet its label in 20 months,” and a manufacturer should be able to show you both. The mechanics of reading the document are in how to read a Certificate of Analysis.

One documentation point matters here. The overage belongs in the master manufacturing record as a deliberate formulation input, distinct from the release specification the CoA is checked against. A shop that can point to the overage, its stability basis, the release spec, and the assay is showing you a decision that was engineered. A shop that can’t is showing you a habit.

Questions that tell you an overage was engineered, not defaulted

You don’t need to run the stability math yourself. You need to know whether your manufacturer did. These questions separate an overage read from data from a percentage applied out of habit. Bring them to any manufacturer, Apollo included.

• Is my overage set from stability data for this exact formula, format, and packaging, or a default percentage you apply across products? A flat number across every product is the tell that it wasn’t read from your data.
• Which of my ingredients are the fragile ones, and how much of the overage is riding on them? The answer should be per-ingredient, not one figure for the blend.
• Are we stabilizing the formulation first (pH, antioxidants, protected forms, packaging) before leaning on overage? Stabilization is the durable fix; overage is the buffer that’s left.
• For any ingredient with an upper intake limit (vitamin A, vitamin D, iron, selenium, niacin, B6), how does the overage stay clear of the ceiling at the labeled serving? This should get a specific answer, not a shrug.
• Is the overage documented in the master manufacturing record, separate from the release specification? It should be a recorded input, not an undocumented adjustment.
• Will my finished-lot CoA show the assayed value, so I can see where the batch sits against claim at release? You want to see the number, not just a “pass.”
• Does my expiration date match what the stability data actually supports, or was the date set first and the overage back-fit to reach it? The date should follow the data; the reverse is how over-fortification happens.

If those answers come back specific and per-ingredient, you’re dealing with a formulation team that treats overage as the compliance decision it is. If they come back as a single blanket percentage, keep asking.

About this information

This article is an educational overview for brand owners and operators. It is not legal, regulatory, or medical advice. Laws, regulations, and marketplace policies change frequently and vary by jurisdiction and by where and how a product is sold, including how a given ingredient is classified and what its labeled amount and shelf life may claim. Regulatory citations are provided for orientation and were checked against the Code of Federal Regulations and the sources listed above as of the review date; they are not a substitute for current primary sources. Verify current requirements with qualified counsel or regulatory professionals before acting. Information is current as of July 2026. Apollo Future Labs supports manufacturing execution: formulation, stability testing coordination, and documentation; your counsel and regulatory advisors decide your compliance strategy.